Trevi Therapeutics, a clinical-stage biopharmaceutical company, announced its senior management will participate in several investor and analyst events in May 2026 to discuss its investigational therapy Haduvio™ for chronic cough related to idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (ILD), and refractory chronic cough (RCC). These events include an Investor and Analyst Day in New York, the Bank of America Global Healthcare Conference in Las Vegas, and a data presentation at the American Thoracic Society International Conference in Orlando. Haduvio™ is notable as the first investigational therapy to show significant reduction in cough frequency in clinical trials for these conditions, which currently have no FDA-approved treatments. The company aims to highlight the therapy's potential impact on improving quality of life for patients suffering from severe chronic cough.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Brazil Potash Corp. disclosed a procedural filing by the Brazilian Federal Public Defender’s Office seeking to suspend activities at its Autazes potash project. The filing challenges prior favorable court decisions but does not introduce new facts or...
DT Midstream, Inc. will announce its financial results for the second quarter of 2026 before the market opens on July 30, 2026. The company has scheduled a conference call at 9:00 a.m. ET on the same day to discuss the results. Investors and the publ...
UK GDP grew 0.8% over three months, beating expectations and showing resilience despite geopolitical risks. The FTSE 100 opened lower amid mixed company results, with major takeovers announced for Rotork (£4.1bn by ABB), Gooch & Housego (£345.6m by A...
Bitcoin briefly reached a three-week high near $65,600 before retreating to around $64,000, influenced by lower-than-expected US inflation data and geopolitical tensions. Ethereum also reversed from a six-week peak near $1,950, slipping below $1,900....
